Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Autoantibodies against aquaporin-4 (AQP4), a water channel in CNS astrocytes, are detected in ∼50-80% of patients with neuromyelitis optica spectrum disorders (NMOsd), characterized by longitudinally extensive transverse myelitis (LETM) and/or optic neuritis. Although these autoantibodies present an...
Main Authors: | John S Tzartos, Christos Stergiou, Konstantinos Kilidireas, Paraskevi Zisimopoulou, Thomas Thomaidis, Socrates J Tzartos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3781161?pdf=render |
Similar Items
-
Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
by: Pittock, S, et al.
Published: (2019) -
Aquaporin-4 Autoantibodies From Neuromyelitis Optica Spectrum Disorder Patients Induce Complement-Independent Immunopathologies in Mice
by: Leung-Wah Yick, et al.
Published: (2018-06-01) -
Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
by: Konstantinos Lazaridis, et al.
Published: (2020-02-01) -
Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
by: Min, J, et al.
Published: (2010) -
Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction Models
by: Liang Wang, et al.
Published: (2022-03-01)